2Cusack JC, Giaceo GG, Clear] K, et al. Survival factors in 186 patients younger than 40 years old with coloretal adenocareinoma,J Am Coll Surg, 1996; 183(2) : 105.
4Szynglarewicz B, Grzebieniak Z, Forgacz J, et al. Prognostic significance of clinical and pathomorphological factors in colorectal cancer: a uni - and multivariate analysis[ J]. Poi Merkuriusz Lek,2004,17(102) :586 - 589.
5Kubota K, Akasu T, Fujita S, et al. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas [ J ]. Hepatogastroenter - ology,2004,51 (55) :142 - 146.
6Stelzner S, Hellmich G, Koch R, et al. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis[ J ]. J Surg Oncol,2005 Mar 15,89 (4) :211 - 217.
7Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell - cycle control causing specific inhibition of cyclin D/CDK4 [ J ]. Nature, 1993 Dec 16,366(6456) :704-707.
8Masson - D, Denis - MG, Lustenberger - P. Limitations of CD44v6 amplifi - cation for the detection of tumour cells in the blood of colorectal cancer patients [ J ]. Br - J - Cancer, 2000,82 (7) : 1283 - 1289.
9Imazeki F, Yokosuka O, Yarnaguehi T, et al. Expression of variant CD44 messenger RNA in colorectal adenocareinomas and adenomatous polys in humans[ J ]. Gastroenlerology, 1996,110:362 - 3688.
10Endl E, Hollmann C, Gerdes J, et al. Antibodies against the Ki67 protein:assessment of the growth fraction and tools for cell cycle analysis [ J]. Methods Cell Biol,2001,63:399 -418.
